EXPANDING THE BOUNDARY OF IN SILICO

EXPANDING THE BOUNDARY OF INSILICO

INDUCED PROXIMITY MEETS DEEP LEARNING

Building on nature's blueprint to leverage the cell’s most powerful systems against disease

EVOLUTIONARY-DRIVEN MOLECULAR DESIGN

VantAI's evolutionary scoring learns from naturally occurring interfaces, allowing our generative models to design smaller, more glue-like molecules

TERNARY COMPLEX ENGINEERING

Industry leading ternary complex modeling performance

TARGET-EFFECTOR MATCHMAKER

Systematic prioritization between each target and the full spectrum of potential effectors, utilizing VantAI’s evolutionary Deep Learning

NOVEL EFFECTOR DISCOVERY

Identification and inaugural recruitment of novel effector platforms through advanced systems biology algorithms, powered by an industry-leading knowledge graph

Induced proximity meets Deep Learning

Building on nature's blueprint to leverage the cell’s most powerful systems against disease

EVOLUTIONARILY-DRIVEN DESIGN

VantAI's evolutionary scoring learns from naturally occurring interfaces, allowing our generative models to design smaller, more glue-like molecules

TERNARY COMPLEX ENGINEERING

Industry leading ternary complex modeling performance

TARGET-EFFECTOR MATCHMAKER

Systematic prioritization between each target and the full spectrum of potential effectors, utilizing VantAI’s evolutionary Deep Learning

NOVEL EFFECTOR DISCOVERY

Identification and inaugural recruitment of novel effector platforms through advanced systems biology algorithms, powered by an industry-leading knowledge graph

OUR TECHNOLOGY

Protein-Contact First Degrader Generation Workflow

ML-driven methodology leverages information about known protein-protein interactions to rapidly build new degraders that can effectively stabilize target-E3 interfaces.

ML-Driven Degradation Prediction

Unique model predicts degradation based on millions of carefully curated protein stability data points.

Degron Knowledge Graph

The world's leading map of the ubiquitin proteasome system connects E3s to specific degron motifs.

High-Throughput Validation

Novel assay workflow for rapidly confirming degradation activity of hundreds of compounds against dozens of targets in vitro.

PRESS RELEASES

July 27, 2023

Geometric Deep Learning Pioneer Michael Bronstein joins VantAI as Chief Scientist in Residence to Help Drive Artificial Intelligence Breakthroughs in Drug Discovery

https://www.globenewswire.com/news-release/2023/07/27/2712140/0/en/Geometric-Deep-Learning-Pioneer-Michael-Bronstein-joins-VantAI-as-Chief-Scientist-in-Residence-to-Help-Drive-Artificial-Intelligence-Breakthroughs-in-Drug-Discovery.html

April 20, 2022

VantAI Forms Research Collaboration with Boehringer Ingelheim to Identify Novel Protein Degraders

https://www.globenewswire.com/en/news-release/2022/04/20/2425335/0/en/VantAI-Forms-Research-Collaboration-with-Boehringer-Ingelheim-to-Identify-Novel-Protein-Degraders.html

April 13, 2022

VantAI Announces Multi-Year Protein Degrader Discovery Collaboration with Janssen

https://www.globenewswire.com/news-release/2022/04/13/2421775/0/en/VantAI-Announces-Multi-Year-Protein-Degrader-Discovery-Collaboration-with-Janssen.html

OUR CUSTOMERS

Biopharma

We power the design and development of novel therapies and find new uses for existing ones.

CRO & OoC

We partner with CROs and organ-on-a-chip companies to offer sponsors a full suite of integrated in silico and wet-lab solutions.

Academia

VantAI’s platform supports cutting-edge research at leading academic labs and non-profit institutions.

Investors

VantAI’s cutting-edge tools help the world’s sharpest biotech investors identify and assess opportunities.

OUR PARTNERS

Protein-Contact First Degrader Generation Workflow

ML-driven methodology leverages information about known protein-protein interactions to rapidly build new degraders that can effectively stabilize target-E3 interfaces.

ML-Driven Degradation Prediction

We are obsessed with the potential of AI, but recognize the complexity of biology. It is our mission to see the two intersect in a way that brings maximum impact on disease.

Degron Knowledge Graph

By strategic design, VantAI does not pursue its own clinical pipeline, instead it is our vision to be the AI partner that furthers the potential of hundreds of pharmaceuticals and biotechs around the world.

High-Throughput Validation

Novel assay workflow for rapidly confirming degradation activity of hundreds of compounds against dozens of targets in vitro.

OUR PARTNERS

ABOUT US

Our Mission

Our mission is to write the next chapter of induced proximity

Our Pipeline

We apply our technology to challenging disease targets, both internally and in close collaboration with the worlds leading pharmaceutical companies

Our Team

We are a group of scientists and engineers, convinced that this is the decade AI changes drug discovery forever

MEET OUR TEAM

CAREERS

Want to work with us?

If you are looking for a role at the bleeding edge of artificial intelligence, where your impact is immediate and meaningful, this is it.

‍Apply your skills to help us tackle some of the most complex and meaningful scientific challenges on the planet.

JOIN US

CAREERS

Want to work with us?

Get in touch with us for any questions or comments regarding our abilities, career opportunities, or potential collaborations. We’d love to hear from you.

APPLY NOW

CONTACT US

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.